Jiangxi Fushine Pharmaceutical Co.,Ltd.’s Net Profit Dropped 68.6% in First Quarter of 2022

Jiangxi Fushine Pharmaceutical Co.,Ltd. (江西富祥药业股份有限公司) (300497.SZ) reported a net profit of 23.3 million yuan in the first quarter of 2022, down 68.6% year-on-year.

Meanwhile, the company posted 402.3 million yuan in revenue, up 1.8% year-on-year.

At the end of the reporting period, it had 5 billion yuan in total assets and 2.1 billion yuan in total liabilities, with a liability-to-asset ratio of 42.1%.